3.0.0 4037 2023-07-14T12:30:59Z 2023-07-14T12:30:59Z Senate S 2022-04-07 117 sshr00 Health, Education, Labor, and Pensions Committee Senate Standing Referred to 2022-04-07T17:11:38Z Open Translation and Analysis Center Authorization Act 117 4747 HR 2021-08-04 Referred to the Subcommittee on Asia, the Pacific, Central Asia and Nonproliferation. Identical bill CRS Pharmaceutical Research Transparency Act of 2022 117 7474 HR 2022-04-08 Referred to the Subcommittee on Health. Identical bill CRS 2022-04-07 sshr00 Health, Education, Labor, and Pensions Committee Senate Read twice and referred to the Committee on Health, Education, Labor, and Pensions. IntroReferral 2022-04-07 Introduced in Senate IntroReferral 10000 9 Library of Congress S000770 Sen. Stabenow, Debbie [D-MI] Debbie Stabenow D MI N S001203 Sen. Smith, Tina [D-MN] Tina Smith D MN 2022-04-07 True K000367 Sen. Klobuchar, Amy [D-MN] Amy Klobuchar D MN 2022-11-14 False Health Administrative law and regulatory procedures Department of Health and Human Services Government information and archives Manufacturing Medical research Prescription drugs Research and development Health 00 2022-04-07 Introduced in Senate 2022-07-25T14:22:39Z Pharmaceutical Research Transparency Act of 2022

This bill requires the disclosure of costs associated with clinical trials and pharmaceutical research and development.

Specifically, the National Institutes of Health must create a publicly available repository of cost data from certain clinical trials that test the efficacy of drugs, biological products, and devices in human subjects. For each applicable trial, the registry must, among other information, include the total and per patient cost of the trial, as well as costs for personnel, health care services, and other categories of expenditures. Information must be added to the registry within one year of the trial's completion.

The bill also requires drug manufacturers to include their research and development expenditures for drugs and biological products in annual disclosures made to the Securities and Exchange Commission.

]]> Pharmaceutical Research Transparency Act of 2022 Display Title Pharmaceutical Research Transparency Act of 2022 Short Title(s) as Introduced Pharmaceutical Research Transparency Act of 2022 Introduced in Senate IS Official Title as Introduced A bill to amend the Public Health Service Act to increase the transparency of pharmaceutical research costs, and for other purposes. Introduced in Senate IS Introduced in Senate 2022-04-07T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-117s4037is/xml/BILLS-117s4037is.xml 2022-04-07 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.